KNSA
Kiniksa Pharmaceuticals International, plc
Kiniksa Pharmaceuticals International, plc (KNSA) has 3 SEC Form 4 filings (20 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: May 5, 2026.
The most active filer is CHAIRMAN & CEO Patel Sanj K with 3 filings. Insiders have net sold $29.6M over the trailing 6 months.
- Industry:Medical - Pharmaceuticals
- CEO:Sanj K. Patel
- Employees:366
- HQ:London, MA, GB
- IPO:2018-05-24
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$31.5M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$5.1B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Paolini John F.First filing | CHIEF MEDICAL OFFICER | Sale | 58,424 | $3.1M | May 5 | SEC ↗ |
Patel Sanj KFirst filing | CHAIRMAN & CEO | Sale | 483,654 | $25.1M | Apr 30 | SEC ↗ |
Patel Sanj KFirst filing | CHAIRMAN & CEO | Sale | 22,544 | $1.2M | Apr 30 | SEC ↗ |
Patel Sanj KFirst filing | CHAIRMAN & CEO | Sale | 2,141 | $116K | Apr 30 | SEC ↗ |
Megna Michael RFirst filing | CHIEF ACCOUNTING OFFICER | Sale | 50,490 | $2.0M | Oct 22 | SEC ↗ |
Related companies
Kiniksa Pharmaceuticals International, plc is in the Healthcare sector.